121 related articles for article (PubMed ID: 8330267)
41. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
42. Flow cytometric and karyotypic analysis of a primary small cell carcinoma of the prostate: a xenografted cell line.
Pittman S; Russell PJ; Jelbart ME; Wass J; Raghavan D
Cancer Genet Cytogenet; 1987 May; 26(1):165-9. PubMed ID: 3030535
[TBL] [Abstract][Full Text] [Related]
43. Chromosome studies in thyroid neoplasia.
Bondeson L; Bengtsson A; Bondeson AG; Dahlenfors R; Grimelius L; Wedell B; Mark J
Cancer; 1989 Aug; 64(3):680-5. PubMed ID: 2743263
[TBL] [Abstract][Full Text] [Related]
44. Unbalanced 5;16 translocation in a boy with papillary thyroid carcinoma.
McDonald M; Maynard S; Sheldon S; Innis J
Am J Med Genet; 1994 Feb; 49(3):288-93. PubMed ID: 8209888
[TBL] [Abstract][Full Text] [Related]
45. Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid.
Muro-Cacho CA; Holt T; Klotch D; Mora L; Livingston S; Futran N
Otolaryngol Head Neck Surg; 1999 Feb; 120(2):200-7. PubMed ID: 9949353
[TBL] [Abstract][Full Text] [Related]
46. Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms.
Izumiyama-Shimomura N; Nakamura K; Aida J; Ishikawa N; Kuroiwa M; Hiraishi N; Fujiwara M; Ishikawa Y; Inoshita N; Yonese J; Matsuura M; Poon SS; Arai T; Takubo K
Urol Oncol; 2014 Feb; 32(2):135-45. PubMed ID: 23510865
[TBL] [Abstract][Full Text] [Related]
47. Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82).
König JJ; Hagemeijer A; Smit B; Kamst E; Romijn JC; Schröder FH
Cancer Genet Cytogenet; 1988 Aug; 34(1):91-9. PubMed ID: 3395997
[TBL] [Abstract][Full Text] [Related]
48. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis.
Ciampi R; Nikiforov YE
Endocrinology; 2007 Mar; 148(3):936-41. PubMed ID: 16946010
[TBL] [Abstract][Full Text] [Related]
49. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
50. Establishment and characterization of a human thyroid carcinoma cell line (HOTHC) producing colony stimulating factor.
Ishiwata I; Ono I; Kiguchi K; Ishiwata C; Soma M; Ishikawa H
Hum Cell; 2005 Sep; 18(3):163-9. PubMed ID: 17022149
[TBL] [Abstract][Full Text] [Related]
51. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
Rodrigues R; Roque L; Espadinha C; Pinto A; Domingues R; Dinis J; Catarino A; Pereira T; Leite V
Oncol Rep; 2007 Oct; 18(4):917-26. PubMed ID: 17786355
[TBL] [Abstract][Full Text] [Related]
52. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
[TBL] [Abstract][Full Text] [Related]
53. Chromosomal breakpoints in cholangiocarcinoma cell lines.
Storto PD; Saidman SL; Demetris AJ; Letessier E; Whiteside TL; Gollin SM
Genes Chromosomes Cancer; 1990 Nov; 2(4):300-10. PubMed ID: 2176543
[TBL] [Abstract][Full Text] [Related]
54. Does trisomy 7 occur in a particular cell type in the thyroid?
Cortezzi SS; César AC; Tajara EH; Suzigan S; Góis Filho JF; Fukuyama EE; Ribeiro PR
Cancer Genet Cytogenet; 2002 Jan; 132(1):77-8. PubMed ID: 11801316
[No Abstract] [Full Text] [Related]
55. Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
Xu J; Souter LH; Chambers AF; Rodenhiser DI; Tuck AB
Cancer Genet Cytogenet; 2008 Oct; 186(1):33-40. PubMed ID: 18786440
[TBL] [Abstract][Full Text] [Related]
56. Cytogenetic and fluorescence in situ hybridization studies in a case of anaplastic thyroid carcinoma.
Roque L; Soares J; Castedo S
Cancer Genet Cytogenet; 1998 May; 103(1):7-10. PubMed ID: 9595037
[TBL] [Abstract][Full Text] [Related]
57. Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.
Kubo K; Yoshimoto K; Yokogoshi Y; Tsuyuguchi M; Saito S
Jpn J Cancer Res; 1991 Oct; 82(10):1097-103. PubMed ID: 1683348
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
59. [From the cytogenetics to the cytogenomics of thyroid tumors].
Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
[TBL] [Abstract][Full Text] [Related]
60. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
